Skip to content

The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

Comparison of the Effects of Nifedipine and Magnesium Sulfate on Maternal and Fetal Doppler Blood Flow Patterns in Women With Preterm Labor

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05520021
Acronym
MgSO4
Enrollment
30
Registered
2022-08-29
Start date
2022-09-01
Completion date
2023-03-31
Last updated
2022-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Preterm, Preterm Labor Without Delivery

Keywords

Nifedipine, Magnesium sulfate, pregnancy, preterm labor threat

Brief summary

Comparison of the effects of Nifedipine and MgSO4 therapies on maternal and fetal blood flow.

Detailed description

In this study, the investigators aim to compare the effect of Nifedipine and MgSO4 therapies on Doppler parameters of the uterine, umbilical, middle cerebral arteries, and ductus venous in the first 48 hours of therapy in pregnancies with preterm labor threat and also compare perinatal outcomes after delivery between the groups.

Interventions

DRUGNifedipine

A total of 30 pregnancies with preterm labor threats will be treated with Nifedipine.

DRUGMagnesium sulfate

A total of 30 pregnancies with preterm labor threats will be treated with Magnesium sulfate.

Sponsors

Konya Meram State Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 38 Years
Healthy volunteers
Yes

Inclusion criteria

* pregnancies with preterm labor threat between 28-34 weeks gestational ages

Exclusion criteria

* Cervical dilatation at \> 4 cm and/or cervical effacement \>80%, * Multiple pregnancies, * Pregnancy complications including preeclampsia, ablatio placenta, intrauterine growth restriction, placenta previa, gestational diabetes

Design outcomes

Primary

MeasureTime frameDescription
Doppler parametersGestational age at delivery (weeks)Pulsality index of middle cerebral artery.

Secondary

MeasureTime frameDescription
Perinatal outcomesGestational age at delivery (weeks)NICU admission

Countries

Turkey (Türkiye)

Contacts

Primary ContactMerve Turk
drmerveturk@gmail.com+90 5050 494 20 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026